These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27485478)

  • 1. Multistimuli-Responsive Bilirubin Nanoparticles for Anticancer Therapy.
    Lee Y; Lee S; Lee DY; Yu B; Miao W; Jon S
    Angew Chem Int Ed Engl; 2016 Aug; 55(36):10676-80. PubMed ID: 27485478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronic Acid-Bilirubin Nanoparticles as a Tumor Microenvironment Reactive Oxygen Species-Responsive Nanomedicine for Targeted Cancer Therapy.
    Lee S; Lee SA; Shinn J; Lee Y
    Int J Nanomedicine; 2024; 19():4893-4906. PubMed ID: 38828202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of tumor-homing and pH-responsive polypeptide-doxorubicin nanoparticles with enhanced anticancer efficacy and reduced side effects.
    Hu J; Xie L; Zhao W; Sun M; Liu X; Gao W
    Chem Commun (Camb); 2015 Jul; 51(57):11405-8. PubMed ID: 26086450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of polydopamine as a new and biocompatible coating of magnetic nanoparticles for delivery of doxorubicin in mouse breast adenocarcinoma.
    Zavareh S; Mahdi M; Erfanian S; Hashemi-Moghaddam H
    Cancer Chemother Pharmacol; 2016 Nov; 78(5):1073-1084. PubMed ID: 27752764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotinylated Bilirubin Nanoparticles as a Tumor Microenvironment-Responsive Drug Delivery System for Targeted Cancer Therapy.
    Lee Y; Lee S; Jon S
    Adv Sci (Weinh); 2018 Jun; 5(6):1800017. PubMed ID: 29938184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction/photo dual-responsive polymeric prodrug nanoparticles for programmed siRNA and doxorubicin delivery.
    Wu M; Li J; Lin X; Wei Z; Zhang D; Zhao B; Liu X; Liu J
    Biomater Sci; 2018 May; 6(6):1457-1468. PubMed ID: 29770812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-Delivery of Doxorubicin and Survivin shRNA-Expressing Plasmid Via Microenvironment-Responsive Dendritic Mesoporous Silica Nanoparticles for Synergistic Cancer Therapy.
    Li Z; Zhang L; Tang C; Yin C
    Pharm Res; 2017 Dec; 34(12):2829-2841. PubMed ID: 28948461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fullerene (C60)-based tumor-targeting nanoparticles with "off-on" state for enhanced treatment of cancer.
    Shi J; Wang B; Wang L; Lu T; Fu Y; Zhang H; Zhang Z
    J Control Release; 2016 Aug; 235():245-258. PubMed ID: 27276066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gold nanoparticle-gated mesoporous silica as redox-triggered drug delivery for chemo-photothermal synergistic therapy.
    Yang Y; Lin Y; Di D; Zhang X; Wang D; Zhao Q; Wang S
    J Colloid Interface Sci; 2017 Dec; 508():323-331. PubMed ID: 28843922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polytyrosine nanoparticles enable ultra-high loading of doxorubicin and rapid enzyme-responsive drug release.
    Gu X; Qiu M; Sun H; Zhang J; Cheng L; Deng C; Zhong Z
    Biomater Sci; 2018 May; 6(6):1526-1534. PubMed ID: 29666858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Black Pigment Gallstone Inspired Platinum-Chelated Bilirubin Nanoparticles for Combined Photoacoustic Imaging and Photothermal Therapy of Cancers.
    Lee DY; Kim JY; Lee Y; Lee S; Miao W; Kim HS; Min JJ; Jon S
    Angew Chem Int Ed Engl; 2017 Oct; 56(44):13684-13688. PubMed ID: 28869355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of cytotoxicity profile and intracellular localisation of doxorubicin-loaded chitosan nanoparticles.
    Souto GD; Farhane Z; Casey A; Efeoglu E; McIntyre J; Byrne HJ
    Anal Bioanal Chem; 2016 Aug; 408(20):5443-55. PubMed ID: 27225177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bilirubin Nanoparticle-Assisted Delivery of a Small Molecule-Drug Conjugate for Targeted Cancer Therapy.
    Lee S; Lee Y; Kim H; Lee DY; Jon S
    Biomacromolecules; 2018 Jun; 19(6):2270-2277. PubMed ID: 29712433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
    Yu JM; Li YJ; Qiu LY; Jin Y
    J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticles based on disulfide-containing poly(β-amino ester) and zwitterionic fluorocarbon surfactant as a redox-responsive drug carrier for brain tumor treatment.
    Feng R; Chen Q; Zhou P; Wang Y; Yan H
    Nanotechnology; 2018 Dec; 29(49):495101. PubMed ID: 30211689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-directing star-shaped block copolymers: supramolecular vesicles for the delivery of anticancer drugs.
    Yang C; Liu SQ; Venkataraman S; Gao SJ; Ke X; Chia XT; Hedrick JL; Yang YY
    J Control Release; 2015 Jun; 208():93-105. PubMed ID: 25813888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acidity-Triggered Ligand-Presenting Nanoparticles To Overcome Sequential Drug Delivery Barriers to Tumors.
    Wang T; Wang D; Liu J; Feng B; Zhou F; Zhang H; Zhou L; Yin Q; Zhang Z; Cao Z; Yu H; Li Y
    Nano Lett; 2017 Sep; 17(9):5429-5436. PubMed ID: 28753017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
    Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
    J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smart doxorubicin nanoparticles with high drug payload for enhanced chemotherapy against drug resistance and cancer diagnosis.
    Yu C; Zhou M; Zhang X; Wei W; Chen X; Zhang X
    Nanoscale; 2015 Mar; 7(13):5683-90. PubMed ID: 25740312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A self-assembled polyjuglanin nanoparticle loaded with doxorubicin and anti-Kras siRNA for attenuating multidrug resistance in human lung cancer.
    Wen ZM; Jie J; Zhang Y; Liu H; Peng LP
    Biochem Biophys Res Commun; 2017 Dec; 493(4):1430-1437. PubMed ID: 28958938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.